Literature DB >> 18795314

Rapid regression of retinal hemorrhage and neovascularization in a case of familial exudative vitreoretinopathy treated with intravitreal bevacizumab.

Mizuki Tagami1, Sentaro Kusuhara, Shigeru Honda, Yasutomo Tsukahara, Akira Negi.   

Abstract

PURPOSE: To report a case of familial exudative vitreoretinopathy (FEVR) rapidly resolved by intravitreal injection of bevacizumab.
METHODS: A 36-year-old woman complained about floaters and visual field defect. Funduscopic examinations revealed retinal vessel anastomosis located between the equator and ora serrata in both eyes. The right eye was accompanied with slight vitreous hemorrhage. Since the patient declined retinal cryopexy for cosmetic reasons, intravitreal bevacizumab injections (1.25 mg/0.05 ml) were performed in both eyes.
RESULTS: Treatment resulted in the rapid regression and the accelerated fibrosis of neovascular tissues. At 4-month follow-up in the right eye and 1-month follow-up in the left, no signs of systemic or ocular complications were detected.
CONCLUSIONS: Intravitreal injection of bevacizumab may be considered as an alternative method in treating FEVR.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18795314     DOI: 10.1007/s00417-008-0949-6

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  7 in total

1.  Acute contraction of the proliferative membrane after an intravitreal injection of bevacizumab for advanced retinopathy of prematurity.

Authors:  Shigeru Honda; Hiroaki Hirabayashi; Yasutomo Tsukahara; Akira Negi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-03-05       Impact factor: 3.117

2.  Intravitreal bevacizumab for the management of choroidal neovascularization in age-related macular degeneration.

Authors:  Ziad F Bashshur; Ali Bazarbachi; Alexandre Schakal; Zeina A Haddad; Christelle P El Haibi; Baha' N Noureddin
Journal:  Am J Ophthalmol       Date:  2006-07       Impact factor: 5.258

3.  Familial exudative vitreoretinopathy.

Authors:  V G Criswick; C L Schepens
Journal:  Am J Ophthalmol       Date:  1969-10       Impact factor: 5.258

4.  Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study.

Authors:  Diana Iturralde; Richard F Spaide; Catherine B Meyerle; Jay M Klancnik; Lawrence A Yannuzzi; Yale L Fisher; John Sorenson; Jason S Slakter; K Bailey Freund; Michael Cooney; Howard F Fine
Journal:  Retina       Date:  2006-03       Impact factor: 4.256

5.  Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage.

Authors:  Richard F Spaide; Yale L Fisher
Journal:  Retina       Date:  2006-03       Impact factor: 4.256

6.  Juvenile retinal detachment as a complication of familial exudative vitreoretinopathy.

Authors:  C E van Nouhuys
Journal:  Fortschr Ophthalmol       Date:  1989

7.  Intravitreal injection of bevacizumab (avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II.

Authors:  Helen A Mintz-Hittner; Ronald R Kuffel
Journal:  Retina       Date:  2008-06       Impact factor: 4.256

  7 in total
  6 in total

1.  [Familial exudative vitreoretinopathy].

Authors:  D Finis; J Stammen; A M Joussen
Journal:  Ophthalmologe       Date:  2010-07       Impact factor: 1.059

Review 2.  Anti-Vascular Endothelial Growth Factor and the Evolving Management Paradigm for Retinopathy of Prematurity.

Authors:  Dana Darwish; Ru-Ik Chee; Samir N Patel; Karyn Jonas; Susan Ostmo; J Peter Campbell; Michael F Chiang; R V Paul Chan
Journal:  Asia Pac J Ophthalmol (Phila)       Date:  2018-05-29

3.  The role of intravitreal ranubizumab in the treatment of familial exudative vitreoretinopathy of stage 2 or greater.

Authors:  Yue-Zhu Lu; Guang-Da Deng; Jing-Hua Liu; Hong Yan
Journal:  Int J Ophthalmol       Date:  2018-06-18       Impact factor: 1.779

4.  [Familial exsudative vitreoretinopathy (FEVR) in childhood].

Authors:  A E Laubichler; P Laubichler; D Zapp; M Klopfer; M Ulbig
Journal:  Ophthalmologe       Date:  2018-06       Impact factor: 1.059

Review 5.  Familial Exudative Vitreoretinopathy.

Authors:  Selçuk Sızmaz; Yoshihiro Yonekawa; Michael T Trese
Journal:  Turk J Ophthalmol       Date:  2015-08-05

6.  Diagnosis of complicated FEVR preoperatively and intra-/post-operatively: characteristics and risk factors for diagnostic timing.

Authors:  Fengjie Xia; Jiao Lyu; Ping Fei; Peiquan Zhao
Journal:  BMC Ophthalmol       Date:  2019-06-08       Impact factor: 2.209

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.